Supporting patients receiving oral systemic anti-cancer therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41920846.
- Also identified by DOI 10.1371/journal.pmed.1005022 and PMC identifier 13042832.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Oral systemic anti-cancer therapies improve convenience, but also shift responsibility for treatment management to the patient. Education, communication, and models of care must adapt to support safe, equitable, and sustainable oral anti-cancer treatment.
Medical subject headings
- Neoplasms
- Antineoplastic Agents